Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Amphastar Pharmaceuticals beat estimated earnings by 13.51%, reporting an EPS of $0.42 versus an estimate of $0.37.
Revenue was up $24.97 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.22 which was followed by a 4.06% increase in the share price the next day.
Here’s a look at Amphastar Pharmaceuticals’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.24 | 0.21 | 0.18 | 0.14 |
| EPS Actual | 0.46 | 0.21 | 0.27 | 0.16 |
| Revenue Estimate | 103.24M | 101.78M | 97.26M | 88.94M |
| Revenue Actual | 112.20M | 101.66M | 103.02M | 95.92M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
